ROSELLA Study: Implementation of risk-stratified population screening for Australia’s most common cancers

The ROSELLA (Risk-stratifed Population Cancer Screening Implementation) Implementation Study will explore how genomically-guided risk-stratified cancer screening could be sustainably implemented in Australia.  ROSELLA will seek to support evidence-based policy making through two parallel work packages:

• The first package will interview key stakeholders influential in the design and implementation of population cancer screening, determining evidence gaps, opportunities and barriers to risk-stratified screening. Participants will include policymakers, screening program managers, community members, and GPs. Evidence will be produced to inform a comprehensive implementation strategy and design of a new risk-stratified cancer screening program for the most common cancers in Australia (breast, colorectal, prostate and melanoma).

• The second package will assess how patients respond to taking a DNA cancer risk assessment from their general practice, and how a risk-stratified screening program could be implemented in general practice to ensure all Australians have equitable access to this new program. Five Victorian general practices will be engaged to determine the most-apt approach to screening.

Dr. Sibel Saya, Research Lead/ Research Fellow/ Genetic Counsellor, University of Melbourne

Herman Prof Jon Emery Academic GP, University of Melbourne

A/Prof Nicole Rankin, Implementation Scientist, University of Melbourne

Mr. Matthew Thoenig, Research Officer, University of Melbourne

Adj A/Prof Rebecca Haddock, Policy Advisor, Australian Healthcare and Hospitals Association/ Deakin University

A/Prof Vivienne Milch, Policy Advisor, Cancer Australia

A/Prof Julia Steinberg, Epidemiologist, University of Sydney

Prof Anne Cust, Cancer Epidemiologist, Daffodil Centre (University of Sydney and Cancer Council NSW)

Dr. Amelia Smit, Epidemiologist, University of Sydney

Dr. Erika Spaeth Tuff, Genetic Scientist, Phenogen Sciences/Genetic Technologies

Dr. George Fishman, Community Investigator, Primary Care Collaborative Cancer Clinical Trials Group

Ms. Louise Bailey, Community Investigator, Primary Care Collaborative Cancer Clinical Trials Group